In vitro cytokine secretion in individuals with schizophrenia:: Results, confounding factors, and implications for further research

被引:32
作者
Hinze-Selch, D
Pollmächer, T
机构
[1] Univ Kiel, Dept Psychiat & Psychotherapy, D-24105 Kiel, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
关键词
cytokines; schizophrenia; in vitro; secretion; peripheral blood cells; medication; smoking; antipsychotic drugs;
D O I
10.1006/brbi.2001.0645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present paper reviews the results of all publications on in vitro cytokine secretion in patients with schizophrenia, as published by March 2001. The authors supply easy to read tables with respect to the individual cytokines and soluble cytokine receptors investigated. the in vitro methodology used, characterization of the patient samples, and the results on cytokine secretion as stated in these studies. Inconsistent results. e.g., regarding in vitro secretion of IL-2 with 11/18 studies finding decreased secretion, 5/18 finding no change, and 2/18 finding increases, cannot systematically be correlated with any methodological procedures nor any diagnostic subtypes, per se. However. factors such as medication and cigarette smoking are likely to play a role. The authors suggest that more hypothesis-driven research. together with more carefully designed studies, as well as better communication between basic or animal researchers and clinicians might help to answer the question of whether there are meaningful peripheral changes in the immune system related to schizophrenia. (C) 2001 Elsevier Science.
引用
收藏
页码:282 / 318
页数:37
相关论文
共 165 条
[1]   Mouse tumor necrosis factor-α increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice [J].
Ando, T ;
Dunn, AJ .
NEUROIMMUNOMODULATION, 1999, 6 (05) :319-329
[2]   Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment [J].
Arolt, V ;
Rothermundt, M ;
Wandinger, KP ;
Kirchner, H .
MOLECULAR PSYCHIATRY, 2000, 5 (02) :150-158
[3]   Production of interferon-gamma in families with multiple occurrence of schizophrenia [J].
Arolt, V ;
Weitzsch, C ;
Wilke, I ;
Nolte, A ;
Pinnow, M ;
Rothermundt, M ;
Kirchner, H .
PSYCHIATRY RESEARCH, 1997, 66 (2-3) :145-152
[4]   Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth [J].
Arzt, E ;
Pereda, MP ;
Costas, M ;
Sauer, J ;
Renner, U ;
Holsboer, F ;
Stalla, GK .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :525-531
[5]   Pathophysiological role of the cytokine network in the anterior pituitary gland [J].
Arzt, E ;
Pereda, MP ;
Castro, CP ;
Pagotto, U ;
Renner, U ;
Stalla, GK .
FRONTIERS IN NEUROENDOCRINOLOGY, 1999, 20 (01) :71-95
[6]   MONOCLONAL CYTOLYTIC T-CELL LINES [J].
BAKER, PE ;
GILLIS, S ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (01) :273-278
[7]   RANTES promotes growth and survival of human first-trimester forebrain astrocytes [J].
Bakhiet, M ;
Tjernlund, A ;
Mousa, A ;
Gad, A ;
Strömblad, S ;
Kuziel, WA ;
Seiger, A ;
Andersson, J .
NATURE CELL BIOLOGY, 2001, 3 (02) :150-157
[8]   CYTOKINES IN NEURONAL CELL-TYPES [J].
BARTFAI, T ;
SCHULTZBERG, M .
NEUROCHEMISTRY INTERNATIONAL, 1993, 22 (05) :435-444
[9]  
Be'eri M, 1998, EUR J NEUROSCI, V10, P2707
[10]   Cytokine actions in the central nervous system [J].
Benveniste, EN .
CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (3-4) :259-275